ISTH 2022 Congress
Coagulation and Natural Anticoagulants » Animal Models in Thrombosis and Hemostasis
Theme Navigation
- ISTH 2022 Congress
- Coagulation and Natural Anticoagulants
- Animal Models in Thrombosis and Hemostasis
- Coagulation and Natural Anticoagulants
-
Abstract Number: OC 44.3
A new mouse model of impaired fibrin α-chain crosslinking shows increased venous thrombembolism
-
Abstract Number: PB0530
Characterization of disseminated intravascular coagulation (DIC) in a murine model of fecal-induced peritonitis
-
Abstract Number: PB0526
Evaluation of intracerebral haematoma expansion of the new oral anticoagulants in rats.
-
Abstract Number: PB0528
Experimental investigation of the antiplatelet effect of Zingiber officinale (Ginger) ex vivo and in vitro
-
Abstract Number: VPB0527
Experimental model of rodent disseminated intravascular coagulation
-
Abstract Number: OC 74.2
Generation of zebrafish f9like mutant by CRISPR/Cas9 technology
-
Abstract Number: OC 44.2
Genetic deletion of Prenylcysteine Oxidase 1 (PCYOX1) impairs arterial thrombosis in mice.
-
Abstract Number: PB0525
Icodextrin as anti- adherence molecule affects cancer cells attachment to the fibrin deposits on the peritoneum surface
-
Abstract Number: PB0529
Investigations of the impact of different bleeding disorders using a humanized in vivo mouse model
-
Abstract Number: VPB0531
Thrombotic state of readiness with increase of physical activity